CompletedNCT05820451
Impella Real-World Surveillance of Patients Using Sodium Bicarbonate
Studying Cardiogenic shock
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Abiomed Inc.
- Principal Investigator
- Amin Medjamia, MDAbiomed Inc.
- Intervention
- Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution(device)
- Enrollment
- 312 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2024
Study locations (20)
- University of Alabama, Birmingham, Alabama, United States
- Pima Heart and Vascular (Tuscon Medical Center), Tucson, Arizona, United States
- Arkansas Heart Hospital, Little Rock, Arkansas, United States
- Keck USC Medical Center, Los Angeles, California, United States
- Advent Helath Orlando, Orlando, Florida, United States
- Tampa General Hospital, Tampa, Florida, United States
- Henry Ford, Detroit, Michigan, United States
- Ascension St. John Hospital, Detroit, Michigan, United States
- Providence St. Patrick, Missoula, Montana, United States
- University of Nebraska, Omaha, Nebraska, United States
- Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
- Christ Hospital, Cincinnatti, Ohio, United States
- Montefiore Medical Center - Moses, Portland, Oregon, United States
- Legacy Emanuel, Portland, Oregon, United States
- Oregon Health & Science University, Portland, Oregon, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05820451 on ClinicalTrials.govOther trials for Cardiogenic shock
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07527156Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureInstitute for Clinical and Experimental Medicine
- RECRUITINGNANCT07345559Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic ShockCMC Ambroise Paré
- RECRUITINGNANCT07374289On Scene ECPR in OstravaUniversity Hospital Ostrava
- RECRUITINGNCT07402018Intra-aortic Balloon Counterpulsation (IABC) ComplianceThomas Jefferson University
- RECRUITINGNCT07309029Pre-Emptive LAVA-ECMO for Complex High-Risk TAVRAtlantic Health System
- RECRUITINGNANCT07293923Magenta Elevate™ Clinical Feasibility Study in Cardiogenic ShockMagenta Medical Ltd.
- RECRUITINGNCT07354568Prognosis of Patients With Mixed Cardiogenic-Vasoplegic ShockCentre Hospitalier Universitaire, Amiens
- RECRUITINGNCT06964685Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic ShockAbiomed Inc.